Literature DB >> 2084069

Fluorinated anthracyclines: interactions with DNA.

K C Tonkin1, R C Boston, R T Brownlee, D R Phillips.   

Abstract

Four fluorine containing derivatives of anthracyclines (daunomycin and adriamycin) were synthesised, and comprised C-13, 1,1,1-trifluoroethyl-hydrazones of each anthracycline, and C-14 4-F and 4-CF3-benzoate esters of adriamycin. All four derivatives intercalated into DNA in a manner similar to their parent anthracycline. The ester derivatives exhibited 3-4-fold higher binding affinity to DNA, and slower DNA dissociation kinetics than adriamycin. This stabilisation derives from additional contacts of the C-14 side chain to the DNA minor groove. The hydrazone derivatives showed lower binding affinity to DNA, and dissociated from DNA 3-4 times faster than the parent compound. The 19F resonance of the bound drug was broadened to 120 Hz and shifted 60 Hz downfield (0.32 ppm) relative to the sharp (7.5 Hz) peak of the free drug. These values imply a rapid exchange between the free and DNA bound forms (DNA lifetime greater than 5 ms), with the fluorine group residing in a hydrophobic region in close contact with the DNA minor groove. The 4-8 fold lesser specific potency of the ester derivatives supports the concept that DNA binding is an important factor, but not sole determinant of biological activity of these analogues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2084069     DOI: 10.1007/BF00198591

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  22 in total

1.  Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.

Authors:  G Capranico; P De Isabella; S Penco; S Tinelli; F Zunino
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

2.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

Authors:  J D McGhee; P H von Hippel
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

3.  Daunomycin-DNA dissociation kinetics.

Authors:  D R Phillips; P C Greif; R C Boston
Journal:  Mol Pharmacol       Date:  1988-02       Impact factor: 4.436

4.  Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.

Authors:  J Feigon; W A Denny; W Leupin; D R Kearns
Journal:  J Med Chem       Date:  1984-04       Impact factor: 7.446

Review 5.  Intercalating drugs: DNA binding and molecular pharmacology.

Authors:  W D Wilson; R L Jones
Journal:  Adv Pharmacol Chemother       Date:  1981

6.  A defined molecular-weight distribution of deoxyribonucleic acid after extensive sonication.

Authors:  A W Davis; D R Phillips
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

7.  Conversational SAAM--an interactive program for kinetic analysis of biological systems.

Authors:  R C Boston; P C Greif; M Berman
Journal:  Comput Programs Biomed       Date:  1981 Mar-Jun

Review 8.  Model systems for cardiotoxic effects of anthracyclines.

Authors:  G Zbinden; E Bachmann; C Holderegger
Journal:  Antibiot Chemother (1971)       Date:  1978

9.  Dissociation kinetics of DNA-anthracycline and DNA-anthraquinone complexes determined by stopped-flow spectrophotometry.

Authors:  B M Gandecha; J R Brown; M R Crampton
Journal:  Biochem Pharmacol       Date:  1985-03-15       Impact factor: 5.858

10.  Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).

Authors:  G J Quigley; A H Wang; G Ughetto; G van der Marel; J H van Boom; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  1 in total

1.  Bis-daunomycin hydrazones: interactions with DNA.

Authors:  D R Phillips; R T Brownlee; J A Reiss; P A Scourides
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.